Clinical Trial Update: Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of udenafil in patients with pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED